NCPA Forms Advocacy Center

Published Online: Tuesday, May 17, 2011
Follow Pharmacy_Times:

The National Community Pharmacists Association (NCPA) has created an organization to house all of the organization’s advocacy functions that represent the interests of neighborhood pharmacists and their patients.

John M. Coster, PhD, RPh, has been appointed head of the NCPA Advocacy Center, which will unite the association’s government affairs, grassroots, pharmacy benefit manager (PBM) transparency, professional affairs, and public affairs programs to ensure that advocacy programs have the maximum impact possible.

Coster was most recently in charge of government affairs for the Generic Pharmaceutical Association, and previously served as NCPA’s senior vice president for government affairs during enactment of the 2010 Affordable Care Act.

“We’re excited about the synergy NCPA’s Advocacy Center will provide on behalf of community pharmacists and their patients,” said NCPA President Robert Greenwood, RPh. “Community pharmacists are well-positioned to play an even greater role in America’s health care system through expert medication counseling, improving patient medication adherence and other cost-saving services. I look forward to seeing this team successfully take that case to policymakers, private and public sector health plans, pharmacy stakeholders and patients.”



Related Articles
The National Community Pharmacists Association today praised a Medicare final regulation to discourage Medicare Part D prescription drug plans from paying long-term care pharmacies lower, prorated dispensing fees for "short-cycle" prescriptions.
Seniors would have more convenient access to discounted or "preferred" copays for prescription drugs at their pharmacy of choice under new bipartisan legislation introduced recently and endorsed today by the National Community Pharmacists Association.
The Corrective Action Plan that federal Medicare officials have requested of Aetna is an important first step and the Centers for Medicare & Medicaid Services should go one further by issuing new guidance to all Medicare Part D prescription drug plan sponsors to prevent a 2016 repeat of the Aetna problems experienced in early 2015.
Beneficiaries, CMS, Taxpayers would benefit from uniform approach.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$